149 related articles for article (PubMed ID: 29514506)
1. Neighbourhood Material and Social Deprivation and Exposure to Antidepressant Drug Treatment: A Cohort Study Using Administrative Data.
Lauzier S; Kadachi H; Moisan J; Vanasse A; Lesage A; Fleury MJ; Grégoire JP
Can J Psychiatry; 2018 Oct; 63(10):701-711. PubMed ID: 29514506
[TBL] [Abstract][Full Text] [Related]
2. The impact of the type of insurance plan on adherence and persistence with antidepressants: a matched cohort study.
Assayag J; Forget A; Kettani FZ; Beauchesne MF; Moisan J; Blais L
Can J Psychiatry; 2013 Apr; 58(4):233-9. PubMed ID: 23547647
[TBL] [Abstract][Full Text] [Related]
3. The adequacy of pharmaceutical treatment of schizophrenia in Quebec varies with age, but is not influenced by sex or neighbourhood deprivation.
Brouwers FM; Courteau J; Grégoire JP; Moisan J; Lauzier S; Lesage A; Fleury MJ; Vanasse A
Can J Psychiatry; 2013 Aug; 58(8):456-65. PubMed ID: 23972107
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the adherence and persistence to inhaled corticosteroids among adult patients with public and private drug insurance plans.
Cyr MC; Beauchense MF; Lemiere C; Blais L
J Popul Ther Clin Pharmacol; 2013; 20(1):e26-41. PubMed ID: 23392860
[TBL] [Abstract][Full Text] [Related]
5. Patterns of discontinuation of atypical antipsychotics in the province of Québec: A retrospective prescription claims database analysis.
Moisan J; Grégoire JP
Clin Ther; 2010; 32 Suppl 1():S21-31. PubMed ID: 20152549
[TBL] [Abstract][Full Text] [Related]
6. Health inequalities associated with neighbourhood deprivation in the Quebec population with hypertension in primary prevention of cardiovascular disease.
Vanasse A; Courteau J; Asghari S; Leroux D; Cloutier L
Chronic Dis Inj Can; 2014 Nov; 34(4):181-94. PubMed ID: 25408177
[TBL] [Abstract][Full Text] [Related]
7. Antidepressant treatment persistence in low-income, insured pregnant women.
Wu J; Davis-Ajami ML
J Manag Care Spec Pharm; 2014 Jun; 20(6):631-7. PubMed ID: 24856601
[TBL] [Abstract][Full Text] [Related]
8. Association between community pharmacy loyalty and persistence and implementation of antipsychotic treatment among individuals with schizophrenia.
Zongo FE; Moisan J; Grégoire JP; Lesage A; Dossa AR; Lauzier S
Res Social Adm Pharm; 2018 Jan; 14(1):53-61. PubMed ID: 28077240
[TBL] [Abstract][Full Text] [Related]
9. Predicting persistence to antidepressant treatment in administrative claims data: Considering the influence of refill delays and prior persistence on other medications.
Bushnell GA; Stürmer T; White A; Pate V; Swanson SA; Azrael D; Miller M
J Affect Disord; 2016 May; 196():138-47. PubMed ID: 26921866
[TBL] [Abstract][Full Text] [Related]
10. Perspective of community pharmacists on their practice with patients who have an antidepressant drug treatment: findings from a focus group study.
Guillaumie L; Moisan J; Grégoire JP; Villeneuve D; Beaucage C; Bujold M; Lauzier S
Res Social Adm Pharm; 2015; 11(2):e43-56. PubMed ID: 25443641
[TBL] [Abstract][Full Text] [Related]
11. Exposure to guideline-recommended drugs after a first acute myocardial infarction in older adults: does deprivation matter?
Akator AE; Blais C; Gamache P; Lunghi C; Guénette L
Pharmacoepidemiol Drug Saf; 2020 Feb; 29(2):141-149. PubMed ID: 31797484
[TBL] [Abstract][Full Text] [Related]
12. Duration and adherence of antidepressant treatment (2003 to 2007) based on prescription database.
Serna MC; Cruz I; Real J; Gascó E; Galván L
Eur Psychiatry; 2010 May; 25(4):206-13. PubMed ID: 20005684
[TBL] [Abstract][Full Text] [Related]
13. Impact of drug plans on adherence to and the cost of antihypertensive medications among patients covered by a universal drug insurance program.
Després F; Perreault S; Lalonde L; Forget A; Kettani FZ; Blais L
Can J Cardiol; 2014 May; 30(5):560-7. PubMed ID: 24613090
[TBL] [Abstract][Full Text] [Related]
14. Prescription patterns following first-line new generation antidepressants for depression in Japan: a naturalistic cohort study based on a large claims database.
Furukawa TA; Onishi Y; Hinotsu S; Tajika A; Takeshima N; Shinohara K; Ogawa Y; Hayasaka Y; Kawakami K
J Affect Disord; 2013 Sep; 150(3):916-22. PubMed ID: 23721923
[TBL] [Abstract][Full Text] [Related]
15. Patient characteristics and prescription fill patterns for allergic rhinitis medications, with a focus on montelukast, in a commercially insured population.
Bollinger ME; Diette GB; Chang CL; Stephenson JJ; Sajjan SG; Fan T; Allen-Ramey FC
Clin Ther; 2010 Jun; 32(6):1093-102. PubMed ID: 20637964
[TBL] [Abstract][Full Text] [Related]
16. Costs associated with changes in antidepressant treatment in a managed care population with major depressive disorder.
Schultz J; Joish V
Psychiatr Serv; 2009 Dec; 60(12):1604-11. PubMed ID: 19952150
[TBL] [Abstract][Full Text] [Related]
17. Economic impact of non-persistence to antidepressant therapy in the Quebec community-dwelling elderly population.
Tournier M; Moride Y; Crott R; du Fort GG; Ducruet T
J Affect Disord; 2009 May; 115(1-2):160-6. PubMed ID: 18694602
[TBL] [Abstract][Full Text] [Related]
18. Receiving guideline-concordant pharmacotherapy for major depression: impact on ambulatory and inpatient health service use.
Sewitch MJ; Blais R; Rahme E; Bexton B; Galarneau S
Can J Psychiatry; 2007 Mar; 52(3):191-200. PubMed ID: 17479528
[TBL] [Abstract][Full Text] [Related]
19. Social inequalities in early antidepressant discontinuation.
Bocquier A; Cortaredona S; Verdoux H; Casanova L; Sciortino V; Nauleau S; Verger P
Psychiatr Serv; 2014 May; 65(5):618-25. PubMed ID: 24487546
[TBL] [Abstract][Full Text] [Related]
20. Antidepressant treatment and risk of suicide attempt by adolescents with major depressive disorder: a propensity-adjusted retrospective cohort study.
Valuck RJ; Libby AM; Sills MR; Giese AA; Allen RR
CNS Drugs; 2004; 18(15):1119-32. PubMed ID: 15581382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
